{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:18:51Z","timestamp":1794313131100,"version":"4.9.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.clinbiochem.2013.06.029","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T23:45:32Z","timestamp":1373499932000},"page":"1239-1243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Growth-differentiation factor-15 and tissue doppler \u0131maging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors"],"prefix":"10.1016","volume":"46","author":[{"given":"Derya","family":"Arslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Cihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dogan","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husamettin","family":"Vatansev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Cimen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Koksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Oran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikret","family":"Akyurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejca.2005.11.003","article-title":"Caring for survivors of childhood cancers: the size of the problem","volume":"42","author":"Curry","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0010","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer: challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/annonc\/mdf167","article-title":"Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review","volume":"13","author":"Kremer","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2010.03.003","article-title":"Cardiac side-effects of cancer chemotherapy","volume":"144","author":"Monsuez","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0025","doi-asserted-by":"crossref","first-page":"753481","DOI":"10.5402\/2012\/753481","article-title":"Transthoracic echocardiography in children and young adults with congenital heart disease","volume":"2012","author":"Koestenberger","year":"2012","journal-title":"ISRN Pediatr"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00059-009-3317-3","article-title":"Growth differentiation factor-15: a new biomarker in cardiovascular disease","volume":"34","author":"Kempf","year":"2009","journal-title":"Herz"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pbc.22989","article-title":"Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors","volume":"57","author":"Abosoudah","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/hrt.2003.027516","article-title":"Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function","volume":"90","author":"Dorup","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0050","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ejechocard\/jer186","article-title":"Tissue Doppler imaging in the left ventricle and right ventricle in healthy children: normal age-related peak systolic velocities, timings, and time differences","volume":"12","author":"Van der Hulst","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ahj.2010.06.010","article-title":"Novel biomarkers in cardiovascular disease: update","volume":"160","author":"Hochholzer","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11897-012-0113-9","article-title":"Growth differentiation factor 15 in heart failure: an update","volume":"9","author":"Wollert","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0065","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/eurjhf\/hfq151","article-title":"The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction","volume":"12","author":"Stahrenberg","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/mpo.1135","article-title":"Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines","volume":"36","author":"Bossi","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0075","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2006.09.7451","article-title":"Noninvasive evaluation of late anthracycline cardiactoxicity in childhood cancer survivors","volume":"25","author":"Hudson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00246-010-9878-3","article-title":"Anthracycline-associated cardiotoxicity in survivors of childhood cancer","volume":"32","author":"Trachtenberg","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0085","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial","volume":"122","author":"Anand","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCGENETICS.108.824870","article-title":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study","volume":"2","author":"Kempf","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCULATIONAHA.111.023937","article-title":"Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction","volume":"124","author":"Reichlin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0100","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/eurheartj\/ehr033","article-title":"Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays","volume":"32","author":"Reiter","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0105","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.06.029_bb0110","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013003068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013003068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:40:35Z","timestamp":1757864435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013003068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":22,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0009912013003068"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.06.029","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth-differentiation factor-15 and tissue doppler \u0131maging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}